Hyperlipidemia Flashcards
Liver maintains a pool of cholesterol at all times. What are the routes of what happens to that cholesterol
- broken down into bile acids to be secreted into intestine
- packaged into VLDL to go into circulation
Liver maintains a pool of cholesterol at all times. What are the various sources of this cholesterol
- remnants of chylomicrons
- from LDL taken up through LDL receptors on liver
- make cholesterol from acetyl CoA using HMG-CoA
Where does HDL come from? what it is function?
- extrahepatic takes up LDL and excretes HDL which is then ready to scavenge any free cholesterol found in the blood stream
What is IDL?
- intermediate density lipoprotein
- formed from
- HDL that has picked up cholesterol
- VLDL after it has given free fatty acid to tissues
what happens to intermediate density lipoprotein
They are cleared from the plasma into the liver by receptor-mediated endocytosis, or further degraded to form LDL particles.
cause of familial hypercholesterolemia
LDL receptor deficiency -> leads to high LDL
what happens to cholesterol levels during weight loss
- cholesterol levels are low during weight loss
- check after weight loss has stabilized for one month
in patients with hyperlipidemia, dietary changes should always be instituted first except in patients wtih
- coronary or peripheral vascular disease
- familial hypercholesteremia
MOA of statins
- blocks de novo synthesis of cholesterol
- statins are the structural analog of HMG-CoA reductase
- reduced plasma LDL by inhibiting the reductase to increase high affinity LDL receptors
DOC for decreasing LDL levels
statins
which two of the statin drugs are inactive and hydrolyzed to active form
- Lovastatin
- Simvastatin
why should patients take statins in the evening
- diurnal pattern of cholesterol synthesis; de novo cholesterol synthesis peaks at night
What are the hallmark adverse effects of statins
- increase levels of serum aminotransferase (LFTs)
- Myopathy and muscle pain
when are statins contraindicated
- pregnancy (category X)
- active hepatic disease
metabolism of statins
liver by P450s